Acorda Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Acorda Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2010 to Q1 2024.
  • Acorda Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $130K, a 83.1% increase year-over-year.
  • Acorda Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $537K, a 50.4% decline year-over-year.
  • Acorda Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $478K, a 68% decline from 2022.
  • Acorda Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.5M, a 50.1% decline from 2021.
  • Acorda Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3M, a 63% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $537K $130K +$59K +83.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $478K $139K -$37K -21% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $515K $140K -$224K -61.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $739K $128K -$343K -72.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $1.08M $71K -$414K -85.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $1.5M $176K -$304K -63.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $1.8M $364K -$490K -57.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $2.29M $471K -$483K -50.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $2.77M $485K -$222K -31.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $3M $480K -$1.11M -69.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 $4.1M $854K -$1.63M -65.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $5.73M $954K -$1.1M -53.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $6.83M $707K -$1.27M -64.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $8.1M $1.59M -$1.17M -42.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-18
Q3 2020 $9.27M $2.48M -$812K -24.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $10.1M $2.06M -$2.48M -54.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $12.6M $1.98M -$1.69M -46.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $14.3M $2.76M -$2.22M -44.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 $16.5M $3.29M -$1.84M -35.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $18.3M $4.53M -$710K -13.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $19M $3.67M -$2.23M -37.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $21.3M $4.97M -$1.64M -24.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 $22.9M $5.14M -$1.57M -23.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $24.5M $5.24M -$6.46M -55.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $30.9M $5.9M -$1.9M -24.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $32.8M $6.61M -$2.37M -26.4% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 $35.2M $6.7M -$3.3M -33% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $38.5M $11.7M +$2.4M +25.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $36.1M $7.8M -$300K -3.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $36.4M $8.99M +$221K +2.52% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $36.2M $10M +$1.1M +12.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $35.1M $9.3M +$600K +6.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $34.5M $8.1M +$1M +14.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $33.5M $8.77M -$14K -0.16% Oct 1, 2015 Dec 31, 2015 10-K/A 2018-03-09
Q3 2015 $33.5M $8.9M +$1.6M +21.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $31.9M $8.7M +$1.1M +14.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $30.8M $7.1M +$1.34M +23.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $29.4M $8.78M +$1.54M +21.3% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $27.9M $7.3M +$800K +12.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $27.1M $7.6M +$1.1M +16.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $26M $5.76M +$857K +17.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $25.1M $7.24M +$1.21M +20.1% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $23.9M $6.5M +$900K +16.1% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $23M $6.5M +$900K +16.1% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $22.1M $4.9M +$709K +16.9% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 $21.4M $6.03M +$524K +9.52% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q3 2012 $20.9M $5.6M +$600K +12% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $20.3M $5.6M +$600K +12% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $19.7M $4.19M +$391K +10.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $19.3M $5.5M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-03
Q3 2011 $5M +$200K +4.17% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $5M +$400K +8.7% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 $3.8M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 $4.8M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 $4.6M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.